The electrochemistry of quinizarin revealed through its mediated reduction of oxygen

Edited by Harry B. Gray, California Institute of Technology, Pasadena, CA, and approved October 7, 2011 (received for review August 18, 2011)
November 22, 2011
108 (50) 19891-19895

Abstract

After 35 years the hunt for improved anthracycline antibiotics is unabated but has yet to achieve the levels of clinical success desired. Electrochemical techniques provide a large amount of kinetic and thermodynamic information, but the use of such procedures is hindered by issues of sensitivity and selectivity. This work demonstrates how by harnessing the mechanism of catalytic reduction of oxygen by the quinone functionality present within the anthracycline structure it is possible to study the reactive moiety in nanomolar concentration. This methodology allows electrochemical investigation of the intercalation of quinizarin into DNA and, in particular, the quinone oxidation and degradation mechanism. The reversible reduction of the quinizarin, which in the presence of oxygen leads to the formation of reactive oxygen species, is found to occur at -0.535 V (vs. SCE) pH 6.84 and the irreversible oxidation leading to the molecules degradation occurs at +0.386 V (vs. SCE) pH 6.84.
The anthracycline antibiotic family is known to contain some of the most effective chemotherapeutic drugs available; however their use is hindered by their well-documented cardiotoxicity (1, 2). Although this toxicity is multifactorial, it is predominantly related to the production of reactive oxygen species (ROS) via interaction of the quinone functionality with iron (ferritin) (3). A large body of evidence exists implicating the production of ROS as being the primary cause of cardiomyopathy (1). However, there has been a lack of success to date in improving clinical outcomes through the use of antioxidants and iron-selective chelators as cardiovascular protectants (4). Significantly, recent research has also focused on the possibility of direct quinone-mediated ROS production (Fig. 1A). Within the heart the presence of H2O2, as formed from the reductive anthracycline redox cycling, may lead to degradation of the anthracycline species through its mediated oxidation via myoglobin (Fig. 1B). Post oxidation, it is proposed that the molecule chemically decomposes leading to loss of its redox properties (5). On the basis of this mechanistic route it has been proposed that finding a chemical species which enhances the rate of degradation of the anthracycline antibiotic within the heart may prove to be an effective cardioprotectant (6). This work focuses on the chemistry of quinizarin (QZ), which is the redox-active moiety present in a variety of anthracycline antibiotics, including doxorubicin (DOX) as depicted in Fig. 1.
Fig. 1.
Schematic showing the structure of DOX and highlighting the QZ moiety (blue). Systems A and B are the reduction and oxidation of the QZ moiety, respectively, degradation pathway is not shown (compare to the text). The C-13 carbon has been labeled on the DOX species with a green star.
The majority of the proposed mechanistic routes leading to necrosis of cardiomyoctes are related not to antitumoral activity (notably DNA intercalation and topoisomerase II inhibition) but commonly cite the involvement of the redox properties of the quinone moiety. As such, one may expect electrochemistry to provide significant insights into the processes occurring. In fact this point was realized as early as 1979, when the newly produced 5-iminodaunorubicin was investigated electrochemically to confirm its lower reactivity toward oxygen reduction compared to its parent molecule (7). The further development and use of electrochemical techniques for investigation of the fundamental properties of anthracycline antibiotics and their mimetics has been highly limited. It should be noted that the use of 5-iminodaunorubicin was clinically unsuccessful because of its increased myelotoxicity (8).
Of the electrochemical methodologies available, voltammetry is a powerful experimental tool providing information about both the kinetics and thermodynamics of a system (9). The use of such procedures for investigating biologically relevant systems is often hampered because of sensitivity and selectivity issues, which may have hindered their wider use within pharmacology. Limitation in sensitivity may be understood in terms of the magnitude of the capacitive current relative to the faradic current; for a metallic macroelectrode the limit of detection for a diffusion-only system is often confined to micromolar concentrations, whereby at lower concentrations the faradic current of interest will be smaller than the background capacitive current (9). Given the large number of electroactive species present within most biological systems, voltammetric procedures are somewhat indiscriminate, leading to complex responses. These problems are overcome in this paper through the use of a boron doped diamond (BDD) electrode. BDD is a semiconductor, hence because of the lower density of states present within the material the associated capacitive currents can be up to an order of magnitude lower than that found for metallic-based substrates (10, 11). As a further consequence of the lower density of states the rates of electron transfer are found to be significantly slower (12), such that the direct reduction of oxygen at the electrode interface is not observed within the aqueous electrochemical window. This feature allows the quinone-mediated oxygen reduction to be investigated directly (13). A final significant feature of BDD electrodes is that they commonly exhibit low levels of adsorption of organic species (11, 14), this result is in contrast to the current work.
For the anthracycline antibiotics their electrochemical activity derives from the QZ moiety present within their structures (Fig. 1, highlighted in blue). Hitherto, direct electrochemical study of this moiety has been restricted because of its relatively low solubility within aqueous media (2–5 μM) (15). Work studying the responses of quinones within aqueous media have regularly required addition of charged substituents to enhance the solubility of the species, and hence, increase the analytical signal (16, 17). This study demonstrates how by harnessing the QZ-mediated catalytic reduction of oxygen it is possible to electrochemically investigate the system with solution-phase QZ concentrations as low as 5 nM (∼100 ppt). Further the biologically significant properties of the QZ moiety are probed, specifically DNA intercalation is demonstrated and in particular the oxidative destruction of the molecule seen.

Results and Discussion

The reduction of quinone functionality either by a one or two electron processes is known to produce reactive species, which are able to readily reduce oxygen (Fig. 1A) either to superoxide () or hydrogen peroxide (H2O2). When the reduction of the species occurs at an electrode surface this mechanism results in a catalytic cycle and voltammetrically, a large irreversible redox signal is observed (13). The reduction of the QZ species upon a BDD electrode was investigated in both the presence and absence of dissolved oxygen, where the potential was swept at a scan rate of 0.5 V s-1 between -0.2 V and -0.85 V (vs. SCE), as shown in Fig. 2, where the QZ concentration is 480 nM. It should be noted that because of the low solubility of the QZ molecule within solution the use of a Teflon cell was required to avoid loss of material through adsorption onto glass surfaces. In the absence of oxygen a small surface-bound voltammetric peak was observed at -0.535 V (vs. SCE), and this peak is ascribed to the reversible two electron, two proton reduction of the quinone species (Fig. 1A). It is proposed that because of the low solubility of QZ it readily adsorbs upon the BDD electrode surface, and hence the direct reduction of adsorbed QZ is measurable until a solution concentration of roughly 200 nM. From the charge under the surface-bound voltammetric peak in the presence of 480 nM QZ it is possible to estimate the surface coverage of the QZ molecule as being roughly 2.5 ± 0.5 × 1012 molecules cm-2. From X-ray crystallographic data the molecular volume is found to be ca. 260 3 (18). Using estimated geometric dimensions we can calculate the expected full monolayer coverage of QZ upon the BDD surface to be 1.5–4.0 × 1014 molecules cm-2, depending on the orientation of the species (vertical or horizontal). Hence, this value suggests that at 480 nM the surface coverage of the QZ species is roughly 0.5–2% of a full monolayer coverage.
Fig. 2.
Voltammetric response for the reduction of QZ (480 nM) in the presence (red) and absence (black) of oxygen, scan rate 0.5 V s-1.
In the presence of oxygen, a large irreversible voltammetric feature is observed because of the mediated reduction of oxygen (Fig. 1A). In this study pure oxygen has been used, the application of the following procedures to in vivo studies will likely require the use of lower oxygen concentrations. Significantly the voltammetric response exhibits a sharp switching-off of the current at -0.776 V (vs. SCE). This rapid shift is indicative of the presence of a phase transition; given that material is known to be adsorbed upon the electrode it is reasonable to conclude that this sharp voltammetric feature is related to a change in the orientation of the surface-bound groups at more negative potentials. Further this phase transition also clearly causes the catalytic redox cycle to become nonoperative. This phase transition may be either the desorption of material or a change in alignment of the QZ upon the electrode surface, as is known for quinoline, aniline, and other organic species (19, 20). As the potential is decreased during the reverse scan the material returns to its original orientation switching on the mediated reduction pathway, leading to a rapid increase in current [-0.717 V (vs. SCE)]. Moreover, the voltammogram exhibits hysteresis in the potentials at which the phase transition occurs upon the forward and reverse scan. Given that the surface coverage of the QZ species is known to be very low (0.5–2%) and that if the QZ distribution upon the surface is assumed to be homogenous the redox centers may be expected to be ca. 2 nm apart. At such large interatomic distance, interactions between the redox centers will be minimal, thus the rapidity of the phase change is likely caused by the presence of negative differential resistance leading to bistability within the electrochemical system (21).
The mediated peak current was measured as a function of QZ concentration (Fig. 3), where it was found that measurable peak currents were found for concentrations as low as 5 nM (13.2 ± 3.6 × 10-6A). At higher concentrations the peak current shows a plateau; this limiting of the current is not related to a limitation in the adsorption of the QZ on to the electrode surface. It was found that the voltammetric peak area for the nonmediated process varied linearly with QZ concentration beyond a value of 480 nM. The limitation in the mediated process is more likely related to the consumption of the available oxygen. From literature it is known that the solubility of oxygen within the aqueous solutions is approximately 1.24 mM (22) and the diffusion coefficient has been measured as 1.77 × 10-5 cm2 s-1 (23). Consider the Randles–Ševčík equation for an irreversible process:
[1]
where ip is the peak current (amperes), n is the total number of electrons, n is the number of electrons transferred before the rate determining step (RDS), αRDS is the transfer coefficient for the rate determining step, A is the area of the electrode (cm2), Co is the bulk concentration of the analyte (moles cm-3), Do is the diffusion coefficient (cm2 s-1), and ν is the scan rate (V s-1). The value of (n + αRDS) has been set as 0.5 as measured experimentally from Tafel analysis (i.e., the first electron transfer is the rate determining step). The equation predicts that the maximum peak for the reduction of oxygen is approximately 1.1 × 10-4A (this value is depicted as the horizontal line on the inlay of Fig. 3). As can clearly be seen at relatively high concentrations of QZ the voltammetric peak current approaches the theoretical maximum. This conclusion is further corroborated by the fact that the peak current for the mediated oxygen reduction peak at 480 nM is found to vary with the square root of scan rate (Fig. 3, Inset). As discussed above, the surface coverage of the QZ at the higher concentrations is known; consequently, it is possible to estimate through measurement of the charge passed for the mediated reduction pathway, that on the forward scan each QZ molecule present upon the surface is on average reduced approximately 300 times.
Fig. 3.
Variation in the peak current for the mediated oxygen reduction peak as a function of QZ concentration. Inset depicts the variation in the peak current as a function of the square root of scan rate (QZ = 480 nM). R-S limit indicates the classical Randles–Ševčík peak current for a two electron irreversible reduction [(n + αRDS) = 0.5].
Having investigated the fundamentals of the system, we address the QZ chemistry. The main accepted mode of chemotherapeutic action for the anthracycline antibiotics is through intercalation of the quinonal moiety into dsDNA and subsequent inhibition of the topoisomerase II enzyme (24). To demonstrate the intercalative abilities of QZ, the voltammetric response of an oxygenated solution containing 60 nM QZ was measured, in the presence of increasing concentrations of solution-phase DNA (Fig. 4). The inlay of Fig. 4 depicts the associated voltammograms under conditions in which there is zero (red) and 25 μM (black) DNA. Clearly as the DNA concentration increases the measured voltammetric response for the mediated oxygen reduction decreases. This observed decrease is due to the sequestration of the QZ through intercalation. It is to be noted that this decrease in voltammetric response is not due to blocking of the electrode with increasing DNA concentration, as confirmed through the addition of higher concentrations of QZ to a 25 μM solution of DNA upon which the mediated voltammetric signal returned.
Fig. 4.
Influence of the concentration of DNA present in solution upon the QZ (60 nM) mediated oxygen reduction signal. Inset depicts representative voltammograms for the mediated oxygen reduction in the presence of 0 μM (red) and 25 μM (black) DNA, scan rate 0.5 V s-1.
It is of interest, that given the reported high binding constant for QZ with DNA (25), a relatively large excess of DNA is required to titrate the QZ. This observation suggests that the adsorption of the QZ to the electrode surface is causing a decrease in the measured sensitivity of the system. This interference of the BDD electrode may be best understood in terms of both the preconcentration of QZ onto the electrode surface and also the high number of available adsorption sites present upon the BDD. The preconcentration of the QZ species upon the electrode increases the local effective concentration to roughly 0.6 μM (based on an approximate diffusion layer thickness of 10 μm). This value is consistent with the DNA binding to roughly 1 in 40 base pairs. Moreover, the QZ should not be expected to bind to the DNA in a 1∶1 ratio because of the likely influence of longer-range allosteric effects (26, 27). Further, if we assume that it is possible to attain a near monolayer coverage of QZ, then within the diffusion layer (10 μm) the number of BDD sites, as compared to the intercalative sites in the DNA, will be greater even at DNA concentrations of 25 μM and above. The presence of the nonzero peak current for the mediated oxygen reduction at high concentrations of DNA is also likely a result of the QZ adsorption. Even given this lower sensitivity toward DNA, this current electrochemical method exhibits significantly lower levels of detection than obtainable by comparable UV-visible-based methods (25, 28). This situation arises predominantly because of the ability to study far lower concentrations of QZ in this work.
The main metabolic route for the removal of anthracycline antibiotic from the body is via reduction of the carbonyl group (C-13, as labeled on Fig. 1) (29), but because of the presence of the hydroquinone group within the anthracycline (situated on the quinizarin) the species is also susceptible to oxidative degradation (Fig. 1B). Biologically this reaction is known to occur both directly via oxidation through a peroxidase (30) or alternatively indirectly via the oxidized products of the enzymes (31, 32). Further it has been proposed that the oxidative degradation pathway of the anthracycline species may provide a possible route by which cardiac protection may be attained (8).
The direct oxidation of the QZ species was investigated at the BDD electrode in the presence of dissolved oxygen (0.5 V s-1). At relatively high QZ concentrations (480 nM) the irreversible oxidation of surface-bound species is observed with a half-wave potential of +0.386 V (vs. SCE) (Fig. 5, Inset, blue dotted line). This voltammetric feature corresponds to the 2e-, 2H+ oxidation of the hydroquinone group within the QZ structure (Fig. 1B). In most experimentally measured scan rates no back-peak is observed as the succeeding chemical steps leading the decomposition of the species are rapid. Only at higher scan rates does the evidence of a minimal reverse peak become apparent (as can be seen in Fig. 5, Inset), which may be due to the direct reduction of the products or may also be related to the presence of electroactive decomposition products. The potential of the irreversible oxidative wave was measured as a function of pH where it was confirmed that the peak varied with approximately 59 mV/pH, demonstrating that during the oxidation an equal number of protons and electrons are transferred, further corroborating the conclusion that the peak relates to the 2e-, 2H+ oxidation of the hydroquinone group.
Fig. 5.
Influence of the conditioning potential upon the QZ (480 nm) mediated oxygen reduction peak current. Inset depicts the voltammetric direct oxidation of the QZ adsorbed upon the BDD electrode (0.5 V s-1).
To demonstrate that the oxidation of the species is both related to the QZ and further causes loss of the quinone species, the reductive voltammetric scan was performed (compare to Fig. 2) but here the system was preconditioned at a more positive potential for 15 s prior to running the voltammogram. The results of this experiment can be seen in Fig. 5, where the conditioning potential has been varied between -0.1–0.9 V (vs. SCE). As the potential is systematically increased there is a clear decrease in the measured reduction peak current upon the conditioning potential reaching the potential for the oxidation of the QZ species. This decrease occurs over a potential range of 130–170 mV, hence it may be concluded that the electron transfer is quasireversible in nature. It should be noted that even at high conditioning potentials a nonzero peak current is measured. This current is related to the presence of unreacted QZ present upon the electrode surface, which accumulates via diffusional replenishment after the oxidative potential has been applied. Futhermore, as demonstrated above only nanomolar quantities of QZ are required for a mediated reduction peak to be observed. Hence this experiment has demonstrated that the observed voltammetric feature at +0.386 V (vs. SCE) corresponds to the irreversible oxidation of the QZ species leading to its decomposition.

Conclusions

The use of electrochemical methods for the investigation of biologically relevant systems is often compromised by levels of low sensitivity and selectivity. We have experimentally demonstrated how, through harnessing the catalytic oxygen reduction mechanism, it is possible to observe the presence of the poorly soluble molecule QZ in solution down to 5 nM (∼100 ppt). Further, as QZ forms an active part of the anthracycline antibiotics, the measured electrochemistry gives insight into its biological function. Specifically, this work confirms that oxidation of the quinone functionality cause the degradation of the species and results in the mechanistic pathway that leads to the formation of ROS to be switched off. This oxidation mechanism was found to be pH-dependent confirming that the electrochemical mechanism is associated with proton transfer. This work has wider significance in that it provides direct evidence of the redox properties of the quinone functionality present within anthracycline antibiotics, if this oxidative degradation pathway can be exploited biologically and within the heart it has potential to decrease the cardiotoxicity of future chemotherapy treatments.

Materials and Methods

All chemicals were purchased from Sigma-Aldrich. Solutions were prepared using deionized water of resistivity not less than 18.2 MΩ cm-1 at 298 K (Millipore). Because of the low solubility of the QZ, stock solutions of 0.2 and 0.02 mM QZ in ethanol were prepared. Aliquots of these solutions were added to the aqueous buffer solution (0.1 M phosphate, pH 6.84) to achieve the low QZ concentrations required. The calculation of the low molecular weight DNA (salmon sperm) concentration was done upon the basis of the average base pair molecular weight being 650 gM-1.
The voltammetric measurments were recorded using an Autoloab PGSTAT20 computer-controlled potentiostat (Eco-Chemie). A standard three-electrode configuration was used throughout, consisting of a BDD electrode, a platinum wire (99.99%, GoodFellow), and a saturated calomel electrode (SCE, Radiometer) acting as the working, counter, and reference electrodes, respectively. The BDD electrode was polished by using alumina (1.0, 0.3 μm, Buehler), rinsed, and sonicated for 1 min in deionized water between each experiment. The electrochemical experiments were performed in a Teflon beaker and the solution was either fully oxygenated or deoxgenated by bubbling O2 or N2 through the solution for 15 min, prior to experimentation.

References

1
Y Shi, M Moon, S Dawood, B McManus, PP Liu, Mechanisms and management of doxorubicin cardiotoxicity. Herz 36, 296–305 (2011).
2
D Outomuro, DR Grana, F Azzato, J Milei, Adriamycin-induced myocardial toxicity: New solutions for an old problem? Int J Cardiol 117, 6–15 (2007).
3
G Minotti, G Cairo, E Monti, Role of iron in anthracycline cardiotoxicity: New tunes for an old song? FASEB J 13, 199–212 (1999).
4
L Gianni, et al., Anthracycline cardiotoxicity: From bench to bedside. J Clin Oncol 26, 3777–3784 (2008).
5
P Menna, E Salvatorelli, G Minotti, 4′-epidoxorubicin to reexplore anthracycline degradation in cardiomyocytes. Chem Res Toxicol 22, 978–983 (2009).
6
P Menna, E Salvatorelli, G Minotti, Doxorubicin degradation in cardiomyocytes. J Pharmacol Exp Ther 322, 408–419 (2007).
7
JW Lown, C Hsiao-Hsiung, JA Plambeck, EM Acton, Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents. Biochem Pharmacol 28, 2563–2568 (1979).
8
P Menna, E Salvatorelli, G Minotti, Anthracycline degradation in cardiomyocytes: A journey to oxidative survival. Chem Res Toxicol 23, 6–10 (2010).
9
AJ Bard, LR Faulkner Electrochemical Methods: Fundamentals and Applications (Wiley, New York, 2001).
10
T Watanabe, et al., Giant electric double-layer capacitance of heavily boron-doped diamond electrode. Diamond Relat Mater 19, 772–777 (2010).
11
RL McCreery, Advanced carbon electrode materials for molecular electrochemistry. Chem Rev 108, 2646–2687 (2008).
12
WJ Royea, TW Hamann, BS Brunschwig, NS Lewis, A comparison between interfacial electron-transfer rate constants at metallic and graphite electrodes. J Phys Chem B 110, 19433–19442 (2006).
13
Q Li, C Batchelor-McAuley, NS Lawrence, RS Hartshorne, RG Compton, Semiquinone intermediates in the two-electron reduction of quinones in aqueous media and their exceptionally high reactivity towards oxygen reduction. ChemPhysChem 12, 1255–1257 (2011).
14
RG Compton, JS Foord, F Marken, Electroanalysis at diamond-like and doped-diamond electrodes. Electroanalysis 15, 1349–1363 (2003).
15
T Mukherjee, NJF Dodd, Electron paramagnetic resonance characterization and conformation of daunorubicin semiquinone intermediate implicated in anthracycline metabolism, cardiotoxicity, and anticancer action. Can J Chem 62, 1297–1298 (1984).
16
C Batchelor-McAuley, Q Li, SM Dapin, RG Compton, Voltammetric characterization of DNA intercalators across the full pH range: Anthraquinone-2,6-disulfonate and anthraquinone-2-sulfonate. J Phys Chem B 114, 4094–4100 (2010).
17
PS Guin, S Das, PC Mandal, Sodium 1, 4-dihydroxy-9, 10-anthraquinone- 2-sulphonate interacts with calf thymus DNA in a way that mimics anthracycline antibiotics: An electrochemical and spectroscopic study. J Phys Org Chem 23, 477–482 (2010).
18
S Swaminathan, GD Nigam, Crystal structure of 1∶4 dihydroxyanthraquinone. Curr Sci 36, 541 (1967).
19
C Buess-Herman, L Gierst, Potential step chronocoulometry of dioxygen in aqueous alkaline solutions saturated with isoquinoline. Electrochim Acta 29, 303–309 (1984).
20
P Holmqvist, The determination of polyglycols by a derivative chronopotentiometric method. Anal Chim Acta 89, 315–320 (1977).
21
K Krischer, N Mazouz, P Grauel, Fronts, waves, and stationary patterns in electrochemical systems. Angew Chem Int Ed 40, 850–869 (2001).
22
FJ Millero, F Huang, TB Graham, Solubility of oxygen in some 1-1, 2-1, 1-2, and 2-2 electrolytes as a function of concentration at 25 °C. J Solution Chem 32, 473–487 (2003).
23
P Han, DM Bartels, Temperature dependence of oxygen diffusion in H2O and D2O. J Phys Chem 100, 5597–5602 (1996).
24
AD Treszezamsky, et al., BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II. Cancer Res 67, 7078–7081 (2007).
25
MB Gholivand, S Kashanian, H Peyman, H Roshanfekr, DNA-binding study of anthraquinone derivatives using chemometrics methods. Eur J Med Chem 46, 2630–2638 (2011).
26
JB Chaires, Long-range allosteric effects on the B to Z equilibrium by daunomycin. Biochemistry 24, 7479–7486 (1985).
27
DM Chenoweth, PB Dervan, Allosteric modulation of DNA by small molecules. Proc Natl Acad Sci USA 106, 13175–13179 (2009).
28
PS Guin, S Das, PC Mandal, Interaction of 1,4-dihydroxy-9,10-anthraquinone with calf thymus DNA: A comparison with anthracycline anticancer drugs. J Solution Chem 40, 492–501 (2011).
29
A Skarka, L Skarydova, H Stambergova, V Wsol, Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase. Chem Biol Interact 191, 66–74 (2011).
30
KJ Reszka, ML McCormick, BE Britigan, Oxidation of anthracycline anticancer agents by the peroxidase mimic microperoxidase 11 and hydrogen peroxide. Free Radical Biol Med 35, 78–93 (2003).
31
KJ Reszka, ML McCormick, BE Britigan, Peroxidase- and nitrite-dependent metabolism of the anthracycline anticancer agents daunorubicin and doxorubicin. Biochemistry 40, 15349–15361 (2001).
32
KJ Reszka, LH Britigan, BE Britigan, Oxidation of anthracyclines by peroxidase metabolites of salicylic acid. J Pharmacol Exp Ther 315, 283–290 (2005).

Information & Authors

Information

Published in

The cover image for PNAS Vol.108; No.50
Proceedings of the National Academy of Sciences
Vol. 108 | No. 50
December 13, 2011
PubMed: 22109547

Classifications

Submission history

Published online: November 22, 2011
Published in issue: December 13, 2011

Keywords

  1. electrocatalysis
  2. oxygen reduction
  3. boron-doped diamond

Notes

This article is a PNAS Direct Submission.

Authors

Affiliations

Christopher Batchelor-McAuley
Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, Oxford OX1 3QZ, United Kingdom
Ivan B. Dimov
Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, Oxford OX1 3QZ, United Kingdom
Leigh Aldous
Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, Oxford OX1 3QZ, United Kingdom
Richard G. Compton1 [email protected]
Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, Oxford OX1 3QZ, United Kingdom

Notes

1
To whom correspondence should be addressed. E-mail: [email protected].
Author contributions: C.B.-M. and R.G.C. designed research; I.B.D. performed research; C.B.-M., L.A., and R.G.C. analyzed data; and C.B.-M. and R.G.C. wrote the paper.

Competing Interests

The authors declare no conflict of interest.

Metrics & Citations

Metrics

Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation information is sourced from Crossref Cited-by service.


Altmetrics




Citations

Export the article citation data by selecting a format from the list below and clicking Export.

Cited by

    Loading...

    View Options

    View options

    PDF format

    Download this article as a PDF file

    DOWNLOAD PDF

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Personal login Institutional Login

    Recommend to a librarian

    Recommend PNAS to a Librarian

    Purchase options

    Purchase this article to access the full text.

    Single Article Purchase

    The electrochemistry of quinizarin revealed through its mediated reduction of oxygen
    Proceedings of the National Academy of Sciences
    • Vol. 108
    • No. 50
    • pp. 19837-20271

    Figures

    Tables

    Media

    Share

    Share

    Share article link

    Share on social media